Institute For Myeloma And Bone Cancer Research
- Assets
- $844.6k
- Revenue
- $1.1m
- Investments
- $451.0
- Employees
- 5
- Location
- West Hollywood, CA
- Founding
- 11/2002
- Data as of
- 12/2023
- EIN
- 46-0475333
Organization Overview
Institute For Myeloma And Bone Cancer Research is located in West Hollywood, CA. The organization was established in 2002. According to its NTEE Classification (G30) the organization is classified as: Cancer, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2023, Institute For Myeloma And Bone Cancer Research employed 5 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Institute For Myeloma And Bone Cancer Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Institute For Myeloma And Bone Cancer Research generated $1.1m in total revenue. The organization has seen a slow decline revenue. Over the past 9 years, revenues have fallen by an average of (0.6%) each year. All expenses for the organization totaled $1.3m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
FORM 990 PART I LINE 1 THE INSTITUTE FOR MYELOMA AND BONE CANCER RESERACH IS ESTABLISHED FOR THE FOLLOWING PURPOSES: (I) TO PROMOTE RESEARCH INTO THE CAUSES OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, (II)TO SUPPORT THE DEVELOPMENT OF THERAPIES DESIGNED TO TREAT AND CONTROL MYELOMA, BONE CANCER, AND RELATED DISORDERS, AND (III) TO ADVANCE EFFORTS DIRECTED AT PREVENTING THE DEVELOPMENT OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, INCLUDING THE TREATMENT OF PERSONS HAVING SUCH DISEASES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS.
ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
James R Berenson MD President An | OfficerTrustee | 10 | $0 |
Geo Hartley ESQ Vice Preside | OfficerTrustee | 1.5 | $0 |
Shahrooz Eshaghian MD Secretary | Trustee | 0.75 | $0 |
Cyndie Dunlap Director | Trustee | 0.75 | $0 |
Roger Fischer Director | Trustee | 0.75 | $0 |
Richard Gardiner MD Director | Trustee | 0.75 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $833,907 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $833,907 |
| Total Program Service Revenue | $248,425 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $269 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,146,011 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $244,648 |
| Pension plan accruals and contributions | $10,071 |
| Other employee benefits | $12,542 |
| Payroll taxes | $19,765 |
| Fees for services: Management | $300,000 |
| Fees for services: Legal | $5,215 |
| Fees for services: Accounting | $21,350 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $9,384 |
| Advertising and promotion | $140,340 |
| Office expenses | $14,335 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $153,294 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $883 |
| Interest | $126,491 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,487 |
| Insurance | $39,425 |
| All other expenses | $48,501 |
| Total functional expenses | $1,293,096 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $175,418 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $5,000 |
| Accounts receivable, net | $86 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $570,273 |
| Prepaid expenses and deferred charges | $49,621 |
| Net Land, buildings, and equipment | $29,275 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $451 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $14,513 |
| Total assets | $844,637 |
| Accounts payable and accrued expenses | $116,417 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $2,750,073 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $262,919 |
| Total liabilities | $3,129,409 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | -$2,284,772 |
| Total liabilities and net assets/fund balances | $844,637 |